Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
Timothy I. Michaels, Jennifer Purdon, Alexis Collins, et al.
BMC Psychiatry (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 187

Showing 26-50 of 187 citing articles:

Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca
Gabrielle Agin-Liebes, Richard J. Zeifman, Jason B. Luoma, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 295-308
Open Access | Times Cited: 40
History repeating: A roadmap to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
(2023)
Open Access | Times Cited: 23
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
Amy L. McGuire, I. Glenn Cohen, Dominic A. Sisti, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2414650-e2414650
Open Access | Times Cited: 12
Treatment-Resistant Depression
Marcus Hughes, Steven R. Levine
Elsevier eBooks (2024)
Closed Access | Times Cited: 10
Ethnoracial inclusion in clinical trials of psychedelics: a systematic review
Marcus Hughes, Albert Garcia‐Romeu
EClinicalMedicine (2024) Vol. 74, pp. 102711-102711
Open Access | Times Cited: 8
Culturally informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder
Monnica T. Williams, Sara Reed, Ritika Aggarwal
Journal of Psychedelic Studies (2019) Vol. 4, Iss. 1, pp. 40-50
Open Access | Times Cited: 73
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)
Jeffrey Guss, Robert Krause, Jordan Sloshower
(2020)
Open Access | Times Cited: 61
Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
Simon B. Goldberg, Benjamin Shechet, Christopher R. Nicholas, et al.
Psychological Medicine (2020) Vol. 50, Iss. 16, pp. 2655-2666
Open Access | Times Cited: 51
Psychedelic therapy: a roadmap for wider acceptance and utilization
Mason Marks, I. Glenn Cohen
Nature Medicine (2021) Vol. 27, Iss. 10, pp. 1669-1671
Open Access | Times Cited: 50
Research abuses against people of colour and other vulnerable groups in early psychedelic research
Dana Strauss, Sara de la Salle, Jordan Sloshower, et al.
Journal of Medical Ethics (2021) Vol. 48, Iss. 10, pp. 728-737
Closed Access | Times Cited: 46
Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color
Alan K. Davis, Yitong Xin, Nathan D. Sepeda, et al.
Chronic Stress (2021) Vol. 5
Open Access | Times Cited: 46
Psychedelic drugs and perception: a narrative review of the first era of research
Jacob S. Aday, Julia R. Wood, Emily K. Bloesch, et al.
Reviews in the Neurosciences (2021) Vol. 32, Iss. 5, pp. 559-571
Closed Access | Times Cited: 41
Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias
Andrew Peterson, Emily A. Largent, Holly Fernandez Lynch, et al.
AJOB Neuroscience (2022) Vol. 14, Iss. 2, pp. 107-123
Closed Access | Times Cited: 36
The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review
Lucas Oliveira Maia, Yvan Beaussant, Ana Cláudia Mesquita Garcia
Journal of Pain and Symptom Management (2022) Vol. 63, Iss. 6, pp. e725-e738
Closed Access | Times Cited: 35
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E. Rosa, Zachary Sager, Megan E. Miller, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 35
Counselors’ attitudes toward psychedelics and their use in therapy
Benjamin Hearn, Michael D. Brubaker, George B. Richardson
Journal of Counseling & Development (2022) Vol. 100, Iss. 4, pp. 364-373
Open Access | Times Cited: 33
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality
Grant Jones, Matthew K. Nock
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
Christopher S. Stauffer, Melanie Brown, Dee Adams, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 30
Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation
Nadav Liam Modlin, Tammy M. Miller, James Rucker, et al.
Journal of Affective Disorders (2023) Vol. 326, pp. 18-25
Closed Access | Times Cited: 18
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations
Andrew G. Lee, Daniel Rosenbaum, Daniel Z. Buchman
The Canadian Journal of Psychiatry (2024) Vol. 69, Iss. 5, pp. 309-313
Open Access | Times Cited: 7
Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis
Caroline Peacock, Jennifer S. Mascaro, Erin Brauer, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296071-e0296071
Open Access | Times Cited: 6
Diversity, equity, and access in psychedelic medicine
Monnica T. Williams, Beatriz Caiuby Labate
Journal of Psychedelic Studies (2019) Vol. 4, Iss. 1, pp. 1-3
Open Access | Times Cited: 50
Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists
Monnica T. Williams, Sara Reed, Jamilah R. George
Journal of Psychedelic Studies (2020) Vol. 4, Iss. 3, pp. 125-138
Open Access | Times Cited: 45
Containment Matters: Set and Setting in Contemporary Psychedelic Psychiatry
Tehseen Noorani
Philosophy, psychiatry & psychology (2021) Vol. 28, Iss. 3, pp. 201-216
Open Access | Times Cited: 36

Scroll to top